Analyst
Mizuho
Equibles does not estimate personal net worth.
Brad Bowers is recorded as Analyst at Mizuho. Brad Bowers has spoken on 3 earnings calls and 1 other investor event across 2 companies, most recently for Tempus AI, Inc. on July 30, 2026. Those appearances were for Tempus AI, Inc. (TEM) and Guardant Health, Inc. (GH). The companies whose calls Brad Bowers spoke on are classified in the Healthcare sector.
“And first off, congrats on the large deals that you got this quarter. Wanted to focus specifically on the AstraZeneca piece. Another congratulations on kind of delivering the first version of the model.”
“I actually wanted to hit on profitability, obviously a positive FTA data point here, lowering the COG Shield workflow. And, you know, I know overall we talked about kind of a million tests is kind of a break-in number.”
“A bit of a preamble and then a two-parter here. Just, you know, Tempest doesn't really get any credit as an AI company. I think it trades at four-time sales if you pressure the genomics business, especially the drug discovery stuff and the clinical trial benefits here.”
“Maybe I wanted to get to oncology denomics trends. I feel like we see maybe some more news headlines from competitors just on companion diagnostic status wins.”
Mizuho
Analyst
Transcript header (unverified)
TEM
Health Information Services · Healthcare
